Skip to content

Evoke and Evoke+ Ozempic Drug Trials fail to live up to Dementia promise

Over the last few years, drugs like Ozempic have gained a strong reputation for helping with more than just diabetes and weight loss. These medicines, known as GLP-1 agonists, have shown promise in improving liver, kidney, and heart... (Audio Available – 438 words – 2 minute read time)

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here